Breaking a vicious cycle

Daniel F. Hayes, Jef Allen, Carolyn Compton, Gary Gustavsen, Debra G B Leonard, Robert McCormack, Lee Newcomer, Kristin Pothier, David Ransohoff, Richard L. Schilsky, Ellen Sigal, Sheila E. Taube, Sean R. Tunis

Research output: Contribution to journalArticle

76 Citations (Scopus)

Abstract

Despite prodigious advances in tumor biology research, few tumor-biomarker tests have been adopted as standard clinical practice. This lack of reliable tests stems from a vicious cycle of undervaluation, resulting from inconsistent regulatory standards and reimbursement, as well as insuf cient investment in research and development, scrutiny of biomarker publications by journals, and evidence of analytical validity and clinical utility. We of er recommendations designed to serve as a roadmap to break this vicious cycle and call for a national dialogue, as changes in regulation, reimbursement, investment, peer review, and guidelines development require the participation of all stakeholders.

Original languageEnglish (US)
Article number196cm6
JournalScience Translational Medicine
Volume5
Issue number196
DOIs
StatePublished - Jul 31 2013
Externally publishedYes

Fingerprint

Peer Review
Tumor Biomarkers
Research
Publications
Biomarkers
Guidelines
Neoplasms

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Hayes, D. F., Allen, J., Compton, C., Gustavsen, G., Leonard, D. G. B., McCormack, R., ... Tunis, S. R. (2013). Breaking a vicious cycle. Science Translational Medicine, 5(196), [196cm6]. https://doi.org/10.1126/scitranslmed.3005950

Breaking a vicious cycle. / Hayes, Daniel F.; Allen, Jef; Compton, Carolyn; Gustavsen, Gary; Leonard, Debra G B; McCormack, Robert; Newcomer, Lee; Pothier, Kristin; Ransohoff, David; Schilsky, Richard L.; Sigal, Ellen; Taube, Sheila E.; Tunis, Sean R.

In: Science Translational Medicine, Vol. 5, No. 196, 196cm6, 31.07.2013.

Research output: Contribution to journalArticle

Hayes, DF, Allen, J, Compton, C, Gustavsen, G, Leonard, DGB, McCormack, R, Newcomer, L, Pothier, K, Ransohoff, D, Schilsky, RL, Sigal, E, Taube, SE & Tunis, SR 2013, 'Breaking a vicious cycle', Science Translational Medicine, vol. 5, no. 196, 196cm6. https://doi.org/10.1126/scitranslmed.3005950
Hayes DF, Allen J, Compton C, Gustavsen G, Leonard DGB, McCormack R et al. Breaking a vicious cycle. Science Translational Medicine. 2013 Jul 31;5(196). 196cm6. https://doi.org/10.1126/scitranslmed.3005950
Hayes, Daniel F. ; Allen, Jef ; Compton, Carolyn ; Gustavsen, Gary ; Leonard, Debra G B ; McCormack, Robert ; Newcomer, Lee ; Pothier, Kristin ; Ransohoff, David ; Schilsky, Richard L. ; Sigal, Ellen ; Taube, Sheila E. ; Tunis, Sean R. / Breaking a vicious cycle. In: Science Translational Medicine. 2013 ; Vol. 5, No. 196.
@article{d74e1ca2bea04b6498b6d9efebf3e2d1,
title = "Breaking a vicious cycle",
abstract = "Despite prodigious advances in tumor biology research, few tumor-biomarker tests have been adopted as standard clinical practice. This lack of reliable tests stems from a vicious cycle of undervaluation, resulting from inconsistent regulatory standards and reimbursement, as well as insuf cient investment in research and development, scrutiny of biomarker publications by journals, and evidence of analytical validity and clinical utility. We of er recommendations designed to serve as a roadmap to break this vicious cycle and call for a national dialogue, as changes in regulation, reimbursement, investment, peer review, and guidelines development require the participation of all stakeholders.",
author = "Hayes, {Daniel F.} and Jef Allen and Carolyn Compton and Gary Gustavsen and Leonard, {Debra G B} and Robert McCormack and Lee Newcomer and Kristin Pothier and David Ransohoff and Schilsky, {Richard L.} and Ellen Sigal and Taube, {Sheila E.} and Tunis, {Sean R.}",
year = "2013",
month = "7",
day = "31",
doi = "10.1126/scitranslmed.3005950",
language = "English (US)",
volume = "5",
journal = "Science Translational Medicine",
issn = "1946-6234",
publisher = "American Association for the Advancement of Science",
number = "196",

}

TY - JOUR

T1 - Breaking a vicious cycle

AU - Hayes, Daniel F.

AU - Allen, Jef

AU - Compton, Carolyn

AU - Gustavsen, Gary

AU - Leonard, Debra G B

AU - McCormack, Robert

AU - Newcomer, Lee

AU - Pothier, Kristin

AU - Ransohoff, David

AU - Schilsky, Richard L.

AU - Sigal, Ellen

AU - Taube, Sheila E.

AU - Tunis, Sean R.

PY - 2013/7/31

Y1 - 2013/7/31

N2 - Despite prodigious advances in tumor biology research, few tumor-biomarker tests have been adopted as standard clinical practice. This lack of reliable tests stems from a vicious cycle of undervaluation, resulting from inconsistent regulatory standards and reimbursement, as well as insuf cient investment in research and development, scrutiny of biomarker publications by journals, and evidence of analytical validity and clinical utility. We of er recommendations designed to serve as a roadmap to break this vicious cycle and call for a national dialogue, as changes in regulation, reimbursement, investment, peer review, and guidelines development require the participation of all stakeholders.

AB - Despite prodigious advances in tumor biology research, few tumor-biomarker tests have been adopted as standard clinical practice. This lack of reliable tests stems from a vicious cycle of undervaluation, resulting from inconsistent regulatory standards and reimbursement, as well as insuf cient investment in research and development, scrutiny of biomarker publications by journals, and evidence of analytical validity and clinical utility. We of er recommendations designed to serve as a roadmap to break this vicious cycle and call for a national dialogue, as changes in regulation, reimbursement, investment, peer review, and guidelines development require the participation of all stakeholders.

UR - http://www.scopus.com/inward/record.url?scp=84883882396&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84883882396&partnerID=8YFLogxK

U2 - 10.1126/scitranslmed.3005950

DO - 10.1126/scitranslmed.3005950

M3 - Article

VL - 5

JO - Science Translational Medicine

JF - Science Translational Medicine

SN - 1946-6234

IS - 196

M1 - 196cm6

ER -